The article reports on a wrongful death case involving the antiviral drug Remdesivir. According to the article, a lawyer representing the family of a deceased patient argued that COVID-19 immunity protections for healthcare providers should not apply in this case. The lawyer contends that the use of Remdesivir was not approved by the FDA and that the drug may have contributed to the patient’s death. The article includes quotes from the lawyer and background information on the case, but does not provide a full picture of the legal or medical issues involved. It should be noted that the views presented in the article are highly critical of Remdesivir and the healthcare system, and may not represent the views of mainstream medical or legal professionals.
